Browser-accessed Annual Product Quality Review reporting engine, primarily on-premise or vendor-hosted, that aggregates batch, QC, QA, stability, complaint, and ERP data. Its "Anytime PQR" architecture lets quality teams regenerate a compliant PQR for any selected date range, not only at year-end.
CaliberAPQR (also marketed as "Caliber Anytime PQR") sits in the Caliber "Data & Insights" portfolio alongside CaliberCPV, QUARI by Caliber, CaliberDashboards, CaliberMetrix, and CaliberPulse. It consumes data from upstream Caliber modules (CaliberLIMS, CaliberBRM, EPIQ eQMS, CalibereLog, CaliberIPQC) and third-party systems (SAP, ERPs, Excel) and produces a PQR document plus annexure-level statistics and trends.
The product maps to 21 CFR 211.180(e) (FDA APR/APQR) and EU GMP Chapter 1 §1.10 (PQR), with derivative coverage of ICH Q7 §2.5 and WHO TRS 957 Annex 2. The vendor markets "Anytime PQR" as running a compliant PQR at any selected period, instead of solely once per calendar year (Caliber whitepaper, November 2023).
CaliberAPQR won the "Excellence in Ancillary Pharma Services" award at the India Pharma Awards 2018. It is one of 16+ products in the Caliber portfolio: CaliberLIMS is the flagship, and CaliberAPQR functions as an attach-rate add-on. The installed base is concentrated in India and adjacent regulated markets (Bangladesh, Middle East, Southeast Asia, parts of Africa).
Single-edition product, not packaged as separate pharma, biotech, or device editions. Sold as one configurable platform aimed at GMP drug-product manufacturers. Templates support US APQR (211.180(e)), EU PQR, and WHO Annual Quality Review variants.
Web/browser-based deployment. Capterra lists Web, Android, and iPhone/iPad. Historically sold as on-premise installs in pharma data centres. CaliberLIMS 4.0 is described as "cloud-compatible," but CaliberAPQR is not explicitly offered as multi-tenant SaaS. Deployment is hybrid or on-premise primarily, with vendor-hosted single-tenant available on request.
An API is available, described by the vendor as a "ready to use interface engine for Caliber products," with named connectors for CaliberLIMS, CaliberBRM, EPIQ/QMS, SAP, and generic ERPs. REST/GraphQL/webhook details and connectors to third-party LIMS or MES products are not documented. SSO is listed as a feature. Specific IdPs and protocol support (SAML 2.0 / OIDC) are not documented publicly. Data residency, cloud regions, and benchmark performance metrics are not published.
Subscription, per user, per year. Capterra lists the Basic tier at ₹150,000 per user per year (~US$1,800 at May 2026 INR/USD reference rates). Whether this rate reflects US/EU pricing or India-domestic pricing is unclear. Only the entry tier is published; enterprise, multi-site, and perpetual-licence pricing are undisclosed. No free trial is available. A demo is scheduled via caliberuniversal.com/schedule-demo/.
Deal sizes are not directly disclosed. Caliber Technologies' total operating revenue for FY2023 was INR 1–100 crore, implying typical Caliber-suite deal sizes in the mid-five-figure to low-six-figure USD range, with CaliberAPQR-only deals likely in the mid-five-figure USD range (analyst estimate). Minimum commitments, setup fees, and validation-support fees are not published.
No implementation timeline is published for CaliberAPQR specifically. Indian mid-cap deployments of CaliberLIMS+APQR commonly run 6–9 months end-to-end, based on case-study language. Training options per Capterra include In Person, Live Online, Webinars, Documentation, and Videos. Support tiers include Email/Help Desk, FAQs/Forum, Knowledge Base, Phone Support, 24/7 Live rep, and Chat. Excel/CSV ingestion is documented as a migration capability. Legacy APQR/PQR Word-document migration is not documented.
Independent reviews on the sibling CaliberLIMS flag two recurring concerns: system inflexibility relative to existing SOPs, and slow support cycle times with paid-maintenance-contract gating. Whether these affect CaliberAPQR specifically is unconfirmed.
PharmaSpotter assessment from published vendor and third-party sources. No user reviews are on file for this product.
Users report ease of use, strong fit for Indian-pharma digital-transformation programs, and a configuration-friendly workflow. Capterra reviewer (Admin, pharma): "Very good product and compatible to all digital transformation… Data integrity is very good and implementation." A second reviewer (QC, biotech) cited digitalisation, interface, compliance, audit trails, data transferring, and automation as the chief strengths. Vendor testimonials emphasise audit confidence and cycle-time savings.
Independent negative signal on CaliberAPQR specifically is thin: n=2 incentivized reviews, both 5/5. Across the Caliber product family, sibling CaliberLIMS users reported system inflexibility relative to existing SOPs ("We were expected to change our procedures or policies to fit their system"), slow support cycles ("issues will often take days or weeks to solve"), and ticket access gated to active annual-maintenance contracts. Whether these patterns extend to CaliberAPQR is unconfirmed. Public collateral does not document AI-generated narrative summaries, OCR ingestion, automated CPK colour-coded indicators, or 5-Why root-cause guidance.
Share your experience with CaliberAPQR anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section